Effects of Prevotella copri on insulin, gut microbiota and bile acids.
Jiatai GongQianjin ZhangRuizhi HuXizi YangChengkun FangLiping YaoJing LvLong WangMingkun ShiWentao ZhangSiqi MaHongkun XiangHongfu ZhangDe-Xing HouYulong YinJianhua HeLijun PengShusong WuPublished in: Gut microbes (2024)
Obesity is becoming a major global health problem in children that can cause diseases such as type 2 diabetes and metabolic disorders, which are closely related to the gut microbiota. However, the underlying mechanism remains unclear. In this study, a significant positive correlation was observed between Prevotella copri (P. copri) and obesity in children ( p = 0.003). Next, the effect of P. copri on obesity was explored by using fecal microbiota transplantation (FMT) experiment. Transplantation of P. copri . increased serum levels of fasting blood glucose ( p < 0.01), insulin ( p < 0.01) and interleukin-1β (IL-1β) ( p < 0.05) in high-fat diet (HFD)-induced obese mice, but not in normal mice. Characterization of the gut microbiota indicated that P. copri reduced the relative abundance of the Akkermansia genus in mice ( p < 0.01). Further analysis on bile acids (BAs) revealed that P. copri increased the primary BAs and ursodeoxycholic acid (UDCA) in HFD-induced mice ( p < 0.05). This study demonstrated for the first time that P. copri has a significant positive correlation with obesity in children, and can increase fasting blood glucose and insulin levels in HFD-fed obese mice, which are related to the abundance of Akkermansia genus and bile acids.
Keyphrases
- insulin resistance
- high fat diet
- blood glucose
- high fat diet induced
- glycemic control
- type diabetes
- adipose tissue
- skeletal muscle
- metabolic syndrome
- weight loss
- young adults
- global health
- cardiovascular disease
- public health
- high glucose
- blood pressure
- drug induced
- diabetic rats
- wastewater treatment
- single cell
- oxidative stress